225 related articles for article (PubMed ID: 25375000)
1. The current clinical value of the DCIS Score.
Wood WC; Alvarado M; Buchholz DJ; Hyams D; Hwang S; Manders J; Park C; Solin LJ; White J; Willey S
Oncology (Williston Park); 2014 May; 28 Suppl 2():C2, 1-8, C3. PubMed ID: 25375000
[TBL] [Abstract][Full Text] [Related]
2. Ductal carcinoma in situ of the breast: the importance of morphologic and molecular interactions.
Mardekian SK; Bombonati A; Palazzo JP
Hum Pathol; 2016 Mar; 49():114-23. PubMed ID: 26826418
[TBL] [Abstract][Full Text] [Related]
3. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
4. Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation.
Solin LJ; McCormick B; Recht A; Haffty BG; Taylor ME; Kuske RR; Bornstein BA; McNeese M; Schultz DJ; Fowble BL; Barrett W; Yeh IT; Kurtz JM; Amalric R; Fourquet A
Cancer J Sci Am; 1996; 2(3):158-65. PubMed ID: 9166516
[TBL] [Abstract][Full Text] [Related]
5. Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ.
Manders JB; Kuerer HM; Smith BD; McCluskey C; Farrar WB; Frazier TG; Li L; Leonard CE; Carter DL; Chawla S; Medeiros LE; Guenther JM; Castellini LE; Buchholz DJ; Mamounas EP; Wapnir IL; Horst KC; Chagpar A; Evans SB; Riker AI; Vali FS; Solin LJ; Jablon L; Recht A; Sharma R; Lu R; Sing AP; Hwang ES; White J;
Ann Surg Oncol; 2017 Mar; 24(3):660-668. PubMed ID: 27704370
[TBL] [Abstract][Full Text] [Related]
6. Genomic Assays in Ductal Carcinoma In Situ: Implications for Management Decisions.
Gangi A; Topham A; Lee MC; Sun W; Laronga C
South Med J; 2017 Oct; 110(10):649-653. PubMed ID: 28973706
[TBL] [Abstract][Full Text] [Related]
7. Incorporating margin status information in treatment decisions for women with ductal carcinoma in situ: a decision analysis.
Wang SY; Kuntz K; Tuttle T; Kane R
Breast Cancer Res Treat; 2010 Nov; 124(2):393-402. PubMed ID: 20848183
[TBL] [Abstract][Full Text] [Related]
8. Controversies in the Treatment of Ductal Carcinoma in Situ.
Barrio AV; Van Zee KJ
Annu Rev Med; 2017 Jan; 68():197-211. PubMed ID: 28099081
[TBL] [Abstract][Full Text] [Related]
9. The impact of genomic testing on the recommendation for radiation therapy in patients with ductal carcinoma in situ: A prospective clinical utility assessment of the 12-gene DCIS score™ result.
Alvarado M; Carter DL; Guenther JM; Hagans J; Lei RY; Leonard CE; Manders J; Sing AP; Broder MS; Cherepanov D; Chang E; Eagan M; Hsiao W; Schultz MJ
J Surg Oncol; 2015 Jun; 111(8):935-40. PubMed ID: 26031501
[TBL] [Abstract][Full Text] [Related]
10. Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.
Martínez-Pérez C; Turnbull AK; Ekatah GE; Arthur LM; Sims AH; Thomas JS; Dixon JM
Cancer Treat Rev; 2017 Apr; 55():163-172. PubMed ID: 28402908
[TBL] [Abstract][Full Text] [Related]
11. San Antonio Breast Cancer Symposium explores DCIS "battleground".
Gottlieb N
J Natl Cancer Inst; 2000 Feb; 92(4):295-7. PubMed ID: 10675372
[No Abstract] [Full Text] [Related]
12. Ductal carcinoma in situ: a disease entity that merits more recognition.
Dereere E; Papadimitriou K; Tjalma W; Altintas S
Minerva Chir; 2015 Aug; 70(4):231-9. PubMed ID: 25916193
[TBL] [Abstract][Full Text] [Related]
13. Will oncotype DX DCIS testing guide therapy? A single-institution correlation of oncotype DX DCIS results with histopathologic findings and clinical management decisions.
Lin CY; Mooney K; Choy W; Yang SR; Barry-Holson K; Horst K; Wapnir I; Allison K
Mod Pathol; 2018 Apr; 31(4):562-568. PubMed ID: 29243740
[TBL] [Abstract][Full Text] [Related]
14. Who should not undergo breast conservation?
Nijenhuis MV; Rutgers EJ
Breast; 2013 Aug; 22 Suppl 2():S110-4. PubMed ID: 24074770
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study.
Zhou W; Jirström K; Johansson C; Amini RM; Blomqvist C; Agbaje O; Wärnberg F
BMC Cancer; 2010 Nov; 10():653. PubMed ID: 21118480
[TBL] [Abstract][Full Text] [Related]
16. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives.
Sakorafas GH; Tsiotou AG
Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968
[TBL] [Abstract][Full Text] [Related]
17. A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk.
Klimov S; Miligy IM; Gertych A; Jiang Y; Toss MS; Rida P; Ellis IO; Green A; Krishnamurti U; Rakha EA; Aneja R
Breast Cancer Res; 2019 Jul; 21(1):83. PubMed ID: 31358020
[TBL] [Abstract][Full Text] [Related]
18. Surgery and adjuvant radiotherapy for unilateral ductal carcinoma in situ (DCIS) in women aged over 70 years: A population based cohort study.
Jauhari Y; Gannon MR; Tsang C; Horgan K; Dodwell D; Clements K; Medina J; Tang S; Pettengell R; Cromwell DA
Eur J Surg Oncol; 2019 Aug; 45(8):1378-1387. PubMed ID: 30878169
[TBL] [Abstract][Full Text] [Related]
19. Validation of a Ductal Carcinoma
Weinmann S; Leo MC; Francisco M; Jenkins CL; Barry T; Leesman G; Linke SP; Whitworth PW; Patel R; Pellicane J; Wärnberg F; Bremer T
Clin Cancer Res; 2020 Aug; 26(15):4054-4063. PubMed ID: 32341032
[TBL] [Abstract][Full Text] [Related]
20. Ductal Carcinoma In Situ: Treatment Update and Current Trends.
Mitchell KB; Kuerer H
Curr Oncol Rep; 2015 Nov; 17(11):48. PubMed ID: 26373411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]